Anacor and Institute for OneWorld Health partnered to discover antibacterial compounds to treat shigellosis

Anacor Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Institute for OneWorld Health

U.S. / Non-Profit or Major Disease Foundation

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced